Christine Deuschel Cornioley
Directeur/Bestuurslid bij Biocartis SA
Profiel
Christine Deuschel Cornioley is currently a Non-Executive Director at Biocartis SA since 2012.
Previously, she held positions such as Chief Executive Officer at Athelas SA, Non-Executive Director at Biocartis Group NV, Vice President-Portfolio & Project Management at Debiopharm International SA from 1995 to 2018, and Chief Scientific Officer at Anteis SA. She has also worked as a Faculty Member at the University of Bern.
Dr. Cornioley obtained a doctorate degree from the University of Fribourg in 1987 and holds an MBA from the Swiss Federal Institute of Technology, the University of Lausanne, and École des Hautes Études Commerciales de Paris.
Actieve functies van Christine Deuschel Cornioley
| Bedrijven | Functie | Begin |
|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Christine Deuschel Cornioley
| Bedrijven | Functie | Einde |
|---|---|---|
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | 01-01-2018 |
| BIOCARTIS GROUP NV | Directeur/Bestuurslid | - |
| Athelas SA | Algemeen Directeur | - |
Anteis SA
 Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Hoofd Techniek/Wetenschap/O&O | - |
| University of Bern | Corporate Officer/Principal | - |
Opleiding van Christine Deuschel Cornioley
| University of Fribourg | Doctorate Degree |
| Swiss Federal Institute of Technology | Masters Business Admin |
| University of Lausanne | Masters Business Admin |
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOCARTIS GROUP NV | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
| Athelas SA | Commercial Services |
Anteis SA
Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |